Literature DB >> 17978056

Plasma vascular endothelial growth Factor-A (VEGF-A) and VEGF-A gene polymorphism are associated with hydrocele development in lymphatic filariasis.

Alexander Yaw Debrah1, Sabine Mand, Mohammad Reza Toliat, Yeboah Marfo-Debrekyei, Linda Batsa, Peter Nürnberg, Bernard Lawson, Ohene Adjei, Achim Hoerauf, Kenneth Pfarr.   

Abstract

Hydrocele is a build-up of fluid in the scrotal regions of a proportion of men infected with the filarial nematode Wuchereria bancrofti. Vascular endothelial growth factors (VEGF) are major mediators of vascular permeability and angiogenesis in the development and progression of many diseases, making them candidates in hydrocele development. We assessed the role of VEGF-A genetic polymorphisms in hydrocele development in a cohort of lymphatic filariasis patients from Ghana. Three VEGF-A promoter polymorphisms were examined. The C/C genotype at -460 was significantly higher in hydrocele patients ([P = 0.0007], OR = 3.8 [95% CI = 1.9-8.2]) than in non-hydrocele patients. Furthermore, plasma levels of VEGF-A were significantly higher in subjects with the C/C genotype than in those with other genotypes. Also, a positive correlation (R(2) = 0.412, P = 0.026) was observed between plasma VEGF-A and stage of hydrocele. The data suggest that the C polymorphism at -460 is a genetic risk factor for hydrocele development in lymphatic filariasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17978056

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  22 in total

Review 1.  Lymphatics in human lymphatic filariasis: in vitro models of parasite-induced lymphatic remodeling.

Authors:  Sasisekhar Bennuru; Thomas B Nutman
Journal:  Lymphat Res Biol       Date:  2009-12       Impact factor: 2.589

2.  Arbonematodes - nematode infections transmissible by arthropods: arbeitskreis blut, untergruppe «bewertung blutassoziierter krankheitserreger»*.

Authors:  Lutz Gürtler; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen
Journal:  Transfus Med Hemother       Date:  2013-01-07       Impact factor: 3.747

Review 3.  Immunopathogenesis of lymphatic filarial disease.

Authors:  Subash Babu; Thomas B Nutman
Journal:  Semin Immunopathol       Date:  2012-10-03       Impact factor: 9.623

4.  Association between Toll-like receptor 2 (TLR2) polymorphisms and asymptomatic bancroftian filariasis.

Authors:  Alisa Junpee; Tewin Tencomnao; Vivornpun Sanprasert; Surang Nuchprayoon
Journal:  Parasitol Res       Date:  2010-06-05       Impact factor: 2.289

5.  A feedback loop between Wolbachia and the Drosophila gurken mRNP complex influences Wolbachia titer.

Authors:  Laura R Serbus; Amy Ferreccio; Mariya Zhukova; Chanel L McMorris; Elena Kiseleva; William Sullivan
Journal:  J Cell Sci       Date:  2011-12-22       Impact factor: 5.285

Review 6.  Insights into the pathogenesis of disease in human lymphatic filariasis.

Authors:  Thomas B Nutman
Journal:  Lymphat Res Biol       Date:  2013-09       Impact factor: 2.589

Review 7.  Vascular endothelial growth factor signaling in acute myeloid leukemia.

Authors:  Kim R Kampen; Arja Ter Elst; Eveline S J M de Bont
Journal:  Cell Mol Life Sci       Date:  2012-07-26       Impact factor: 9.261

Review 8.  Filariasis and lymphoedema.

Authors:  K M Pfarr; A Y Debrah; S Specht; A Hoerauf
Journal:  Parasite Immunol       Date:  2009-11       Impact factor: 2.280

9.  Lymphangiogenesis and lymphatic remodeling induced by filarial parasites: implications for pathogenesis.

Authors:  Sasisekhar Bennuru; Thomas B Nutman
Journal:  PLoS Pathog       Date:  2009-12-11       Impact factor: 6.823

10.  Wolbachia lipoprotein stimulates innate and adaptive immunity through Toll-like receptors 2 and 6 to induce disease manifestations of filariasis.

Authors:  Joseph D Turner; R Stuart Langley; Kelly L Johnston; Katrin Gentil; Louise Ford; Bo Wu; Maia Graham; Faye Sharpley; Barton Slatko; Eric Pearlman; Mark J Taylor
Journal:  J Biol Chem       Date:  2009-05-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.